Zusammenfassung
Die extrakorporale Membranoxygenierung (ECMO) stellt heute im Rahmen klinischer Algorithmen einen wichtigen Baustein in der Therapie des schweren akuten Lungenversagens (ARDS) dar, nachdem sich in observationellen Studien der Wert dieses Verfahrens für die ARDS-Therapie trotz fehlender positiver kontrollierter Studien gezeigt hat. In spezialisierten Zentren wird bei Patienten mit drohender Hypoxie nach Anwendung verschiedener konservativer Therapieverfahren die ECMO unter Integration von Blutpumpen und künstlichen Membranlungen (Oxygenatoren) als Lungenersatzverfahren angewandt. Die Neuentwicklung von Oberflächenbeschichtungen, optimierten Oxygenatoren und miniaturisierten Blutpumpen sollte in der Zukunft sowohl die Hämokompatibilität steigern als auch die klinische Anwendung vereinfachen und komplikationsärmer machen. Die Entwicklung von Oxygenatoren mit deutlich niedrigeren Strömungswiderständen ermöglicht dabei die klinische Anwendung als pumpenloses, durch die arteriovenöse Druckdifferenz getriebenes Lungenunterstützungsverfahren (ECLA). Diese Neuentwicklungen könnten in der Zukunft zur Anwendung der ECMO nicht mehr nur als „ultima ratio“, sondern auch bei weniger schwerem ARDS führen, um lungenprotektivere, weniger invasive Beatmungsformen zu ermöglichen.
Abstract
After various observational studies demonstrated a benefit of extracorporeal membrane oxygenation (ECMO) in the therapy of severe acute respiratory distress syndrome (ARDS), ECMO now represents an important contribution for ARDS therapy using clinical algorithms despite a lack of positive controlled studies. In specialized centers patients with severe ARDS and imminent hypoxia despite intensive conventional therapy, are treated with ECMO using blood pumps and artificial membrane lungs (oxygenators) for extracorporeal lung assist. The development of new surface modifications, optimized oxygenators and miniaturized blood pumps should increase hemocompatibility and lead to simplified treatment as well as less complications. New oxygenators with significantly decreased blood resistance allow the clinical application of pumpless arteriovenous extracorporeal lung assist (ECLA). After these new developments indications for ECMO could be extended from use not only as ultima ratio but to less severe ARDS to enable lung protective, less invasive mechanical ventilation.
Literatur
Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2:319–323
Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW (1976) Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22:80–93
Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB (2000) Extracorporeal life support: the University of Michigan experience. JAMA 283:904–908
Beardsmore C, Dundas I, Poole K, Enock K, Stocks J (2000) Respiratory function in survivors of the United Kingdom extracorporeal membrane oxygenation trial. Am J Respir Crit Care Med 161:1129–1135
Bernard GR, Artigas A, Brigham KL et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Bindslev L, Eklund J, Norlander O et al. (1987) Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology 67:117–120
Brower RG, Matthay M, Schoenfeld D (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials. Am J Respir Crit Care Med 166:1515–1517
Clowes GH, Hopkins AL, Neville WE (1956) An artificial lung dependent upon diffusion of oxygen and carbon dioxide through plastic membranes. J Thorac Cardiovasc Surg 32:630–637
Conrad SA, Zwischenberger JB, Grier LR, Alpard SK, Bidani A (2001) Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 27:1340–1351
Dembinski R, Kopp R, Henzler D et al. (2003) Extracorporeal gas exchange with the Deltastream rotary blood pump in experimental lung injury. Artif Organs 27:530–536
Gattinoni L, Pesenti A, Mascheroni D et al. (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886
Gibbon JH (1937) Artificial maintenance of circulation during experimental occlusion of pulmonary artery. Arch Surg 34:1105–1131
Hill JD, O’Brien TG, Murray JJ (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). N Engl J Med 286:629–634
Kopp R, Kuhlen R, Max M, Rossaint R (2002) Evidence-based medicine in the therapy of the acute respiratory distress syndrome. Intensive Care Med 28:244–255
Lewandowski K (2000) Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 4:156–168
Lewandowski K (2001) Epidemiologie und Pathophysiologie des akuten Lungenversagens. Intensivmedizin 38:426–436
Lewandowski K, Rossaint R, Pappert D et al. (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23:819–835
Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE (2000) Pumpless extracorporeal lung assist—experience with the first 20 cases. Eur J Cardiothorac Surg 17:608–613
Linden V, Palmer K, Reinhard J, Westman R, Ehren H, Granholm T, Frenckner B (2000) High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 26:1630–1637
Meinhardt JP, Quintel M (2003) Extrakorporale Membranoxygenierung (ECMO) im Erwachsenenalter. Intensivmedizin 39:694–706
Mols G, Loop T, Hermle G, Buttler J, Huber B, Schubert J, Benzing A (2001) 10 Jahre Erfahrung mit extrakorporaler Membranoxygenierung. Anasthesiol Intensivmed Notfallmed Schmerzther 36:4–14
Morris AH, Wallace CJ, Menlove RL et al. (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305
Pappert D, Rossaint R, Gerlach H, Falke KJ (1996) Extracorporeal membrane oxygenation. In: Evans TW, Haslett C (eds) ARDS Acute respiratory distress syndrome. Chapman & Hall, London, pp 425–437
Peek GJ, Moore HM, Moore N, Sosnowski AW, Firmin RK (1997) Extracorporeal membrane oxygenation for adult respiratory failure. Chest 112:759–764
Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK (2002) Early experience with a polymethylpentene oxygenator for adult extracorporeal life support. ASAIO J 48:480–482
Philipp A, Foltan M, Gietl M et al. (2003) Interventionelle extrakorporale Lungenunterstützung (ILA) mittels arterio-venösem Shunt und einem neu entwickelten Low Resistance Lung Assist Device (LAD). Kardiotechnik 12:7–12
Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J (2000) Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 356:219–220
Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh D, Falke K (1997) Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br J Anaesth 78:241–246
UK-Collaborative ECMO Trial Group (1996) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348:75–82
Ullrich R, Lorber C, Roder G, Urak G, Faryniak B, Sladen RN, Germann P (1999) Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology 91:1577–1586
Wendel HP, Ziemer G (1999) Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 16:342–350
Zapol WM, Snider MT, Hill JD et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196
Zwischenberger JB, Wang D, Lick SD, Deyo DJ, Alpard SK, Chambers SD (2002) The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 74:1011–1016
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Anhang: ARDS-Zentren mit der Möglichkeit der ECMO-Therapie
Anhang: ARDS-Zentren mit der Möglichkeit der ECMO-Therapie
-
Klinik für Anästhesiologie, Universitätsklinikum Aachen, Pauwelstraße 30, 52074 Aachen
-
Klinik für Anästhesiologie und operative Intensivmedizin, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin
-
Anästhesiologische Universitätsklinik Freiburg, Hugstetter Straße 55, 79106 Freiburg
-
Zentrum für Anästhesie, Rettungs- und Intensivmedizin der Georg August Universität, Robert-Koch-Str. 40, 37075 Göttingen
-
Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim
-
Abteilung für Anästhesie und Intensivtherapie, Klinikum der Philips-Universität, Baldingerstr. 1, 35043 Marburg/Lahn
-
Institut für Anästhesiologie, Klinikum Großhadern, Marchioninistr. 15, 81377 München
-
Universitätsklinik für Anästhesiologie und Intensivmedizin, AKH, Woehringer Gürtel 18–20, 1090 Wien
Rights and permissions
About this article
Cite this article
Kopp, R., Henzler, D., Dembinski, R. et al. Extrakorporale Membranoxygenierung beim akuten Lungenversagen. Anaesthesist 53, 168–174 (2004). https://doi.org/10.1007/s00101-003-0643-3
Issue Date:
DOI: https://doi.org/10.1007/s00101-003-0643-3